QureBio Ltd. to Showcase its Q-1802 Clinical Advances at 2022 ASCO Annual Meetings
/PRNewswire/ -- QureBio Ltd., a clinical-stage biopharmaceutical company focusing on bi-specific antibodies and other engineered bio-therapeutics for the...
Stay updated with breaking news from Fbio Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- QureBio Ltd., a clinical-stage biopharmaceutical company focusing on bi-specific antibodies and other engineered bio-therapeutics for the...
To accelerate diagnostic development, the Newcastle-based firm recently snagged a £272,000 Innovate UK grant.
Equities research analysts expect that Entera Bio Ltd. (NASDAQ:ENTX – Get Rating) will announce earnings of ($0.16) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Entera Bio’s earnings. Entera Bio posted earnings per share of ($0.19) during the same quarter last year, which indicates a […]
/PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd., (NASDAQ: EVGN) (TASE: EVGN) and a leading ag-biologicals company focusing on improving food...
Closing Bell: Interest piqued? Not for sliding local markets on Rates Day